OKYONasdaqBiological Products, (No Diagnostic Substances)
OKYO Pharma Ltd
Financials through fiscal 2026, year ended Mar 31, 2026Last filing: 20-F on Jul 20, 2026
$1.40−0.01 (-0.71%)
Close on Oct 19, 2026
- Market cap
- –
- P/E (TTM)
- –
- Dividend yield
- –
OKYO Pharma statistics
Financials through Mar 31, 2026, price as of Oct 19, 2026, median of Biological Products, (No Diagnostic Substances) companies for comparison
Valuation
| Measure | OKYO Pharma | Industry median |
|---|---|---|
| Market Cap | $73.47M | $166.30M |
| Enterprise Value | $58.88M | $88.19M |
Income (trailing twelve months)
| Measure | OKYO Pharma | Industry median |
|---|---|---|
| Pretax Income | -$8.94M | -$14.34M |
| EBITDA | -$8.47M | -$16.91M |
| EPS (Diluted) | -$0.24 | -$0.83 |
Balance sheet
| Measure | OKYO Pharma | Industry median |
|---|---|---|
| Cash & Short-Term Investments | $14.59M | $61.43M |
| Net Cash (Debt) | $14.59M | $15.35M |
| Net Cash Per Share | $0.28 | $0.66 |
| Working Capital | $12.33M | $76.81M |
Financial position
| Measure | OKYO Pharma | Industry median |
|---|---|---|
| Current Ratio | 2.43 | 3.34 |
| Quick Ratio | 1.69 | 2.44 |
Cash flow (trailing twelve months)
| Measure | OKYO Pharma | Industry median |
|---|---|---|
| Operating Cash Flow | -$5.94M | -$12.35M |
| Capital Expenditures | -$6.08K | -$1.08M |
| Free Cash Flow | -$5.94M | -$20.22M |
| FCF Per Share | -$0.11 | -$0.42 |
Efficiency
| Measure | OKYO Pharma | Industry median |
|---|---|---|
| Employee Count | 5 | 74 |
Dividends and yields
| Measure | OKYO Pharma | Industry median |
|---|---|---|
| FCF Yield | -8.09% | -8.72% |
Shares
| Measure | OKYO Pharma | Industry median |
|---|---|---|
| Shares Outstanding | 52,479,500 | 58,127,000 |
| Float | 30,844,500 | 49,136,700 |
| Shares Held by Insiders | 41.2% | 11.6% |
Taxes
| Measure | OKYO Pharma | Industry median |
|---|---|---|
| Income Tax | -$7.99K | $79.87K |
Scores
| Measure | OKYO Pharma | Industry median |
|---|---|---|
| Altman Z-Score | -4.34 | -0.22 |
Calculated by StockData from OKYO Pharma's SEC filings and the latest closing price. Hover a measure to see its formula. The grey column is the median of companies in the same industry group (two-digit SIC code); green or red marks a better or worse value than that median.